BDBM50105111 1-[1-(6-Chloro-benzo[1,3]dioxol-5-ylmethyl)-piperidin-4-yl]-1,4-dihydro-quinoxaline-2,3-dione::CHEMBL325945
SMILES: Clc1cc2OCOc2cc1CN1CCC(CC1)n1c2ccccc2[nH]c(=O)c1=O
InChI Key: InChIKey=VPZVRDLFBIYDOY-UHFFFAOYSA-N
Data: 6 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Delta-type opioid receptor (Homo sapiens (Human)) | BDBM50105111 (1-[1-(6-Chloro-benzo[1,3]dioxol-5-ylmethyl)-piperi...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem | PubMed | n/a | n/a | 620 | n/a | n/a | n/a | n/a | n/a | n/a |
F-59000 Lille Curated by ChEMBL | Assay Description Inhibition of ligand binding to human delta opioid receptor. | J Med Chem 44: 3391-401 (2001) BindingDB Entry DOI: 10.7270/Q2057GN9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
D(4) dopamine receptor (Homo sapiens (Human)) | BDBM50105111 (1-[1-(6-Chloro-benzo[1,3]dioxol-5-ylmethyl)-piperi...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem | PubMed | n/a | n/a | 6.55E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
F-59000 Lille Curated by ChEMBL | Assay Description Inhibition of human dopamine receptor D4.4 | J Med Chem 44: 3391-401 (2001) BindingDB Entry DOI: 10.7270/Q2057GN9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nociceptin receptor (Homo sapiens (Human)) | BDBM50105111 (1-[1-(6-Chloro-benzo[1,3]dioxol-5-ylmethyl)-piperi...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem | PubMed | n/a | n/a | 434 | n/a | n/a | n/a | n/a | n/a | n/a |
F-59000 Lille Curated by ChEMBL | Assay Description Inhibition of human ORL1 orphanin receptor | J Med Chem 44: 3391-401 (2001) BindingDB Entry DOI: 10.7270/Q2057GN9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mu-type opioid receptor (Homo sapiens (Human)) | BDBM50105111 (1-[1-(6-Chloro-benzo[1,3]dioxol-5-ylmethyl)-piperi...) | PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem | PubMed | n/a | n/a | 6.30 | n/a | n/a | n/a | n/a | n/a | n/a |
F-59000 Lille Curated by ChEMBL | Assay Description Binding affinity against mu opiate receptor | J Med Chem 44: 3391-401 (2001) BindingDB Entry DOI: 10.7270/Q2057GN9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Kappa-type opioid receptor (Homo sapiens (Human)) | BDBM50105111 (1-[1-(6-Chloro-benzo[1,3]dioxol-5-ylmethyl)-piperi...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem | PubMed | n/a | n/a | 32 | n/a | n/a | n/a | n/a | n/a | n/a |
F-59000 Lille Curated by ChEMBL | Assay Description Binding affinity against opioid receptor kappa 1 by using [3H]U-69593 as radioligand | J Med Chem 44: 3391-401 (2001) BindingDB Entry DOI: 10.7270/Q2057GN9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Sodium-dependent dopamine transporter (Homo sapiens (Human)) | BDBM50105111 (1-[1-(6-Chloro-benzo[1,3]dioxol-5-ylmethyl)-piperi...) | NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem | PubMed | n/a | n/a | 1.52E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
F-59000 Lille Curated by ChEMBL | Assay Description Binding affinity against dopamine transporter | J Med Chem 44: 3391-401 (2001) BindingDB Entry DOI: 10.7270/Q2057GN9 | |||||||||||
More data for this Ligand-Target Pair |